Data is not available at this time.
Nature's Sunshine Products, Inc. operates in the health and wellness industry, specializing in the manufacturing and distribution of natural health products, including dietary supplements, personal care items, and herbal remedies. The company primarily generates revenue through direct sales, leveraging a global network of independent distributors and a strong e-commerce platform. Its product portfolio targets health-conscious consumers seeking plant-based and scientifically validated solutions, positioning it as a niche player in the competitive wellness market. Nature's Sunshine differentiates itself through rigorous quality control, proprietary formulations, and a vertically integrated supply chain, which enhances product consistency and cost efficiency. The company operates in over 40 countries, with a particularly strong presence in North America, Europe, and Asia, allowing it to capitalize on growing global demand for natural health products. Despite facing competition from larger CPG companies, Nature's Sunshine maintains a loyal customer base due to its heritage as a pioneer in herbal supplements and its focus on holistic wellness.
In FY 2024, Nature's Sunshine reported revenue of $454.4 million, reflecting its steady demand in the health supplements market. Net income stood at $7.7 million, with diluted EPS of $0.40, indicating modest profitability. Operating cash flow was $25.3 million, supported by efficient working capital management, while capital expenditures of $10.97 million suggest ongoing investments in production and distribution capabilities.
The company's earnings power is tempered by competitive pressures and moderate margins, though its asset-light model and direct-to-consumer approach help sustain capital efficiency. With no dividend payouts, retained earnings are likely reinvested into growth initiatives or debt reduction, aligning with its long-term strategic priorities.
Nature's Sunshine maintains a solid balance sheet, with $84.7 million in cash and equivalents providing liquidity. Total debt is relatively low at $14.2 million, indicating a conservative leverage profile. The strong cash position and manageable debt levels suggest financial flexibility to navigate market fluctuations or pursue selective expansion opportunities.
Revenue trends reflect stable demand for natural health products, though growth may be constrained by market saturation in key regions. The company does not currently pay dividends, opting instead to reinvest cash flows into operational improvements and potential acquisitions to drive future expansion.
With a modest net income and EPS, the market likely values Nature's Sunshine based on its niche positioning and cash flow stability rather than aggressive growth prospects. Investor expectations may center on its ability to sustain margins and capitalize on wellness industry tailwinds.
Nature's Sunshine's vertically integrated supply chain and brand legacy provide competitive advantages in quality assurance and customer trust. The outlook hinges on its ability to innovate within the natural health space while optimizing its global distribution network. Challenges include rising input costs and competition, but its strong balance sheet offers resilience.
Company 10-K filings, investor presentations
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |